Burning mouth syndrome.
Burning mouth syndrome (BMS) is a chronic condition characterized by burning of the oral mucosa, with or without dysgeusia and xerostomia, in the setting of no underlying systemic disease or identifiable abnormalities on physical examination or laboratory testing. BMS disproportionately affects postmenopausal women. The pathophysiology of the disease is unknown; no single treatment has proven universally successful. In light of these shortcomings, having a practical approach to the evaluation and management of patients with BMS can improve both patient quality of life and physician satisfaction.
Torgerson
Rochelle R
RR
Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA. torgerson.rochelle@mayo.edu
D000284:Administration, Oral; D000287:Administration, Topical; D000368:Aged; D000777:Anesthetics / Q000008:administration & dosage*; D002054:Burning Mouth Syndrome / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000008:administration & dosage; D010523:Peripheral Nervous System Diseases / Q000150:complications / Q000188:drug therapy; D017698:Postmenopause; D012737:Sex Factors
D000777:Anesthetics; D018377:Neurotransmitter Agents